Kochevar Deborah Turner's Form 4 filing
Charles River Laboratories International, Inc. (CRL) · filed Aug 10, 2021
- Accession no.
- 0001127602-21-023429
- Filed
- Aug 10, 2021
- Trade date
- Aug 6, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.43M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kochevar Deborah TurnerCIK 0001448579 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2021 | Common Stock | MOption exerciseAcquired | +2,539 | $164.24 | +$417,005.36 | 9,622 | Direct | |
| Aug 6, 2021 | Common Stock | SSaleDisposed | −901 | $405.73F1 | −$365,562.73 | 8,721 | Direct | |
| Aug 6, 2021 | Common Stock | SSaleDisposed | −2,620 | $406.67F2 | −$1,065,475.4 | 6,101 | Direct | |
| Aug 6, 2021 | Common Stock | SSaleDisposed | −5 | $407.29 | −$2,036.45 | 6,096 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2021 | Common Stock | MOption exerciseDisposed | −2,539 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades at prices ranging from $405.18 to $406.17. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F2
This transaction was executed in multiple trades at prices ranging from $406.19 to $407.09. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.